Delivery Order SPE2DR25D2010-SPE2DR26F4ZDB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $2,508.14. This non-set-aside contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order is scheduled for completion by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Adderall XR 30 mg capsules (100 count) with a ceiling value of $2,144.00 and a completion date of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $3,492.64. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall XR 25 mg capsules (100 count) with a ceiling value of $1,156.08. This firm fixed price delivery order is scheduled for completion by December 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competitively awarded. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $2,862.68. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a non-set-aside competitive award. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,413.62. This is a firm fixed price delivery order with an ultimate completion date of November 10, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this order at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $5,847.10. This is a firm fixed price delivery order with no set-aside designation, completed competitively through open procurement. The order is scheduled for ultimate completion by November 5, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall XR 10 mg capsules (100 count) with a ceiling value of $2,351.70. This competitive award carries a firm fixed price structure and is scheduled for completion by December 8, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $1,686.07. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) under a firm fixed-price contract structure. The delivery order, valued at $1,452.53, is scheduled for completion by November 17, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded and represents a routine pharmaceutical...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZDBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,457.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare programs and other government healthcare systems worldwide. The company's extensive federal contract portfolio demonstrates its capacity to fulfill competitive pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/3/25 |